Immune interferon in the circulation of patients with autoimmune disease
- PMID: 449915
- DOI: 10.1056/NEJM197907053010102
Immune interferon in the circulation of patients with autoimmune disease
Abstract
The observation that type II, or immune, interferon could be produced by peripheral-blood leukocytes in vitro on an immune-specific basis suggested that it also might be produced in vivo in various autoimmune disorders. We found immune interferon in the serums of patients with systemic lupus erythematosus, rheumatoid arthritis, scleroderma and Sjögren's syndrome. Among 28 patients with systemic lupus erythematosus, 71 per cent of those with active and 21 per cent of those with inactive disease showed interferon in their serums. Serial serum samples showed a good correlation between interferon titers and disease activity. Moreover, interferon titers correlated positively with antibodies to DNA and negatively with serum levels of the third component of complement. It is possible that the production of interferon may contribute to immunologic aberrations in auto-immune diseases and also protect the already compromised host from viral infections.
Similar articles
-
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.J Immunol. 1985 Sep;135(3):2005-14. J Immunol. 1985. PMID: 4020137
-
[Laboratory diagnosis of polysystemic autoimmune diseases].Orv Hetil. 2005 Feb 27;146(9):403-9. Orv Hetil. 2005. PMID: 15830607 Review. Hungarian.
-
Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.Ann N Y Acad Sci. 2005 Jun;1050:217-28. doi: 10.1196/annals.1313.023. Ann N Y Acad Sci. 2005. PMID: 16014537 Review.
-
[Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].Z Arztl Fortbild (Jena). 1992 Mar 10;86(5):217-22. Z Arztl Fortbild (Jena). 1992. PMID: 1585674 German. No abstract available.
-
[Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].Schweiz Med Wochenschr. 1974 Nov 9;104(45):1614-23. Schweiz Med Wochenschr. 1974. PMID: 4612703 German. No abstract available.
Cited by
-
Systemic lupus erythematosus: pathogenesis and targeted therapy.Mol Biomed. 2024 Oct 30;5(1):54. doi: 10.1186/s43556-024-00217-8. Mol Biomed. 2024. PMID: 39472388 Free PMC article. Review.
-
Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review.Rheumatol Int. 2020 Nov;40(11):1903-1910. doi: 10.1007/s00296-020-04653-x. Epub 2020 Jul 20. Rheumatol Int. 2020. PMID: 32691099 Free PMC article. Review.
-
Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus.Rheumatol Immunol Res. 2021 Dec 15;2(3):173-184. doi: 10.2478/rir-2021-0023. eCollection 2021 Sep. Rheumatol Immunol Res. 2021. PMID: 36465073 Free PMC article. Review.
-
B cell lymphokines in human systemic lupus erythematosus.Ann Rheum Dis. 1989 Nov;48(11):941-5. doi: 10.1136/ard.48.11.941. Ann Rheum Dis. 1989. PMID: 2596884 Free PMC article.
-
Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.Clin Exp Immunol. 2016 Dec;186(3):304-312. doi: 10.1111/cei.12865. Epub 2016 Oct 4. Clin Exp Immunol. 2016. PMID: 27613139 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources